158 related articles for article (PubMed ID: 38172220)
1. N-glycan profiling of tissue samples to aid breast cancer subtyping.
Benesova I; Nenutil R; Urminsky A; Lattova E; Uhrik L; Grell P; Kokas FZ; Halamkova J; Zdrahal Z; Vojtesek B; Novotny MV; Hernychova L
Sci Rep; 2024 Jan; 14(1):320. PubMed ID: 38172220
[TBL] [Abstract][Full Text] [Related]
2. Increases in Tumor N-Glycan Polylactosamines Associated with Advanced HER2-Positive and Triple-Negative Breast Cancer Tissues.
Scott DA; Casadonte R; Cardinali B; Spruill L; Mehta AS; Carli F; Simone N; Kriegsmann M; Del Mastro L; Kriegsmann J; Drake RR
Proteomics Clin Appl; 2019 Jan; 13(1):e1800014. PubMed ID: 30592377
[TBL] [Abstract][Full Text] [Related]
3. Molecular signatures of tumor progression in myxoid liposarcoma identified by N-glycan mass spectrometry imaging.
Heijs B; Holst-Bernal S; de Graaff MA; Briaire-de Bruijn IH; Rodriguez-Girondo M; van de Sande MAJ; Wuhrer M; McDonnell LA; Bovée JVMG
Lab Invest; 2020 Sep; 100(9):1252-1261. PubMed ID: 32341520
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
5. N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease.
Leijon H; Kaprio T; Heiskanen A; Satomaa T; Hiltunen JO; Miettinen MM; Arola J; Haglund C
J Clin Endocrinol Metab; 2017 Nov; 102(11):3990-4000. PubMed ID: 28938401
[TBL] [Abstract][Full Text] [Related]
6. Detection of Hanganutziu-Deicher antigens in O-glycans from pig heart tissues by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Jeong HJ; Adhya M; Park HM; Kim YG; Kim BG
Xenotransplantation; 2013; 20(6):407-17. PubMed ID: 23855430
[TBL] [Abstract][Full Text] [Related]
7. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.
Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH
Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.
Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G
J Proteome Res; 2019 Jun; 18(6):2559-2570. PubMed ID: 30889355
[TBL] [Abstract][Full Text] [Related]
9. Defining the human kidney N-glycome in normal and cancer tissues using MALDI imaging mass spectrometry.
Drake RR; McDowell C; West C; David F; Powers TW; Nowling T; Bruner E; Mehta AS; Angel PM; Marlow LA; Tun HW; Copland JA
J Mass Spectrom; 2020 Apr; 55(4):e4490. PubMed ID: 31860772
[TBL] [Abstract][Full Text] [Related]
10. N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome.
Terkelsen T; Haakensen VD; Saldova R; Gromov P; Hansen MK; Stöckmann H; Lingjaerde OC; Børresen-Dale AL; Papaleo E; Helland Å; Rudd PM; Gromova I
Mol Oncol; 2018 Jun; 12(6):972-990. PubMed ID: 29698574
[TBL] [Abstract][Full Text] [Related]
11. High-mannose type N-glycans with core fucosylation and complex-type N-glycans with terminal neuraminic acid residues are unique to porcine islets.
Nanno Y; Shajahan A; Sonon RN; Azadi P; Hering BJ; Burlak C
PLoS One; 2020; 15(11):e0241249. PubMed ID: 33170858
[TBL] [Abstract][Full Text] [Related]
12. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
13. Rapid quantitative profiling of N-glycan by the glycan-labeling method using 3-aminoquinoline/α-cyano-4-hydroxycinnamic acid.
Kaneshiro K; Watanabe M; Terasawa K; Uchimura H; Fukuyama Y; Iwamoto S; Sato TA; Shimizu K; Tsujimoto G; Tanaka K
Anal Chem; 2012 Aug; 84(16):7146-51. PubMed ID: 22830976
[TBL] [Abstract][Full Text] [Related]
14. An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry.
Wallace EN; West CA; McDowell CT; Lu X; Bruner E; Mehta AS; Aoki-Kinoshita KF; Angel PM; Drake RR
Sci Rep; 2024 Jan; 14(1):489. PubMed ID: 38177192
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive N-glycome profiling of cultured human epithelial breast cells identifies unique secretome N-glycosylation signatures enabling tumorigenic subtype classification.
Lee LY; Thaysen-Andersen M; Baker MS; Packer NH; Hancock WS; Fanayan S
J Proteome Res; 2014 Nov; 13(11):4783-95. PubMed ID: 25210975
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of ovarian tumor classification by improved reproducibility in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of serum glycans.
Park CW; Jo Y; Jo EJ
Anal Biochem; 2013 Dec; 443(1):58-65. PubMed ID: 23969014
[TBL] [Abstract][Full Text] [Related]
17. Apo-H (beta-2-glycoprotein) intact N-glycan analysis by MALDI-TOF-MS using sialic acid derivatization.
Javeed R; Hussain D; Jabeen F; Sajid MS; Fatima B; Ashiq MN; Najam-Ul-Haq M
Anal Bioanal Chem; 2021 Dec; 413(30):7441-7449. PubMed ID: 34686894
[TBL] [Abstract][Full Text] [Related]
18. Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis.
Ščupáková K; Adelaja OT; Balluff B; Ayyappan V; Tressler CM; Jenkinson NM; Claes BS; Bowman AP; Cimino-Mathews AM; White MJ; Argani P; Heeren RM; Glunde K
JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34752419
[TBL] [Abstract][Full Text] [Related]
19. Insights into the hyperglycosylation of human chorionic gonadotropin revealed by glycomics analysis.
Ibeto L; Antonopoulos A; Grassi P; Pang PC; Panico M; Bobdiwala S; Al-Memar M; Davis P; Davis M; Norman Taylor J; Almeida P; Johnson MR; Harvey R; Bourne T; Seckl M; Clark G; Haslam SM; Dell A
PLoS One; 2020; 15(2):e0228507. PubMed ID: 32045434
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
